Scynexis (SCYX) EBT Margin Growth (1y) (2014 - 2025)
Scynexis (SCYX) EBT Margin Growth (1y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 342.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -166.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5,404.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -1,258.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 8,812.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2,773.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 132.00 |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 51,712.00 |
| Sep 30, 2025 | -208,685.00 |
| Jun 30, 2025 | 145,964.00 |
| Mar 31, 2025 | -216,627.00 |
| Dec 31, 2024 | -11,626.00 |
| Sep 30, 2024 | -38,553.00 |
| Jun 30, 2024 | -205,741.00 |
| Mar 31, 2024 | 306,648.00 |
| Dec 31, 2023 | 61,107.00 |
| Sep 30, 2023 | 180,029.00 |
| Jun 30, 2023 | 110,170.00 |
| Mar 31, 2023 | -154,773.00 |
| Dec 31, 2022 | 395,984.00 |
| Sep 30, 2022 | -177,313.00 |
| Mar 31, 2022 | -142,047.00 |
| Jun 30, 2019 | -463,117.00 |
| Mar 31, 2019 | -957,969.00 |
| Dec 31, 2018 | -242,500.00 |
| Sep 30, 2018 | -917,031.00 |
| Jun 30, 2018 | 232,812.00 |